{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:38:42Z","timestamp":1775075922170,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0727-y","type":"journal-article","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T08:28:24Z","timestamp":1509179304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Differential diagnosis of thrombotic microangiopathy in nephrology"],"prefix":"10.1186","volume":"18","author":[{"given":"T.","family":"Sakari Jokiranta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Viklicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Al Shorafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Gasteyger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Macia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Pankratenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O\u011fuz","family":"Soylemezoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Tsimaratos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,28]]},"reference":[{"issue":"5","key":"727_CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","volume":"35","author":"JM Campistol","year":"2015","unstructured":"Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2015;35(5):421\u201347.","journal-title":"Nefrologia"},{"issue":"2","key":"727_CR2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/trf.13359","volume":"56","author":"NT Connell","year":"2016","unstructured":"Connell NT, Cheves T, Sweeney JD. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura. Transfusion. 2016;56(2):354\u20139.","journal-title":"Transfusion"},{"issue":"4","key":"727_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-010-1637-4","volume":"26","author":"L Keir","year":"2011","unstructured":"Keir L, Coward RJ. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol. 2011;26(4):523\u201333.","journal-title":"Pediatr Nephrol"},{"key":"727_CR4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","volume":"24","author":"G Ariceta","year":"2009","unstructured":"Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009;24:687\u201396.","journal-title":"Pediatr Nephrol"},{"key":"727_CR5","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368:2169\u201381.","journal-title":"N Engl J Med"},{"issue":"3","key":"727_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","volume":"89","author":"LA Greenbaum","year":"2016","unstructured":"Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 2016;89(3):701\u201311.","journal-title":"Kidney Int"},{"key":"727_CR7","doi-asserted-by":"crossref","unstructured":"Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, et al. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. Am J Kidney Dis. 2016; [Epub ahead of print]","DOI":"10.1053\/j.ajkd.2015.12.034"},{"key":"727_CR8","doi-asserted-by":"crossref","unstructured":"Walle JV, Delmas Y, Ardissino G, Wang J, Kincaid JF, Haller H. Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment. J Nephrol. 2016; [Epub ahead of print]","DOI":"10.1007\/s40620-016-0288-3"},{"issue":"2","key":"727_CR9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.juro.2008.10.041","volume":"181","author":"P Dahm","year":"2009","unstructured":"Dahm P, Yeung LL, Gallucci M, Simone G, Sch\u00fcnemann HJ. How to use a clinical practice guideline. J Urol. 2009;181(2):472\u20139.","journal-title":"J Urol"},{"issue":"1","key":"727_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31(1):15\u201339.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"727_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323\u201335.","journal-title":"Br J Haematol"},{"issue":"Suppl 11","key":"727_CR12","first-page":"2","volume":"14","author":"J Laurence","year":"2016","unstructured":"Laurence J, Haller H, Mannuccio Mannucci P, Nangaku M, Praga M, Rodriguez de Cordoba S. Atypical Hemolytic Uremic Syndrome (aHUS): essential aspects of an accurate diagnosis. Clin Adv Hematol Oncol. 2016;14(Suppl 11):2.","journal-title":"Clin Adv Hematol Oncol"},{"key":"727_CR13","unstructured":"Living with atypical hemolytic uremic syndrome poll. 2016. http:\/\/www.ahusallianceaction.org\/graphs-insights-results-from-the-2016-ahus-global-poll\/ . Accessed 29 Oct 2016."},{"key":"727_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjh.12718","volume":"164","author":"M Scully","year":"2014","unstructured":"Scully M, Goodship T. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol. 2014;164:759\u201366.","journal-title":"Br J Haematol"},{"key":"727_CR15","first-page":"121","volume":"70","author":"D Westra","year":"2012","unstructured":"Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NCA. new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med. 2012;70:121\u20139.","journal-title":"Neth J Med"},{"key":"727_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","volume":"112","author":"JE Sadler","year":"2008","unstructured":"Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008;112:11\u20138.","journal-title":"Blood"},{"key":"727_CR17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaim\u00e9 F, Dragon-Durey MA, Ngo S, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;8:554\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"727_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fped.2014.00097","volume":"2","author":"J Hofer","year":"2014","unstructured":"Hofer J, Rosales A, Fischer C, Giner T. Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr. 2014;2:97.","journal-title":"Front Pediatr"},{"issue":"10","key":"727_CR19","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5(10):1844\u201359.","journal-title":"Clin J Am Soc Nephrol"},{"key":"727_CR20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","volume":"33","author":"D Kavanagh","year":"2013","unstructured":"Kavanagh D, Goodship TH, Richards A. Atypical haemolytic uremic syndrome. Semin Nephrol. 2013;33:508\u201330.","journal-title":"Semin Nephrol"},{"key":"727_CR21","doi-asserted-by":"crossref","unstructured":"Fakhouri F, Fila M, Prov\u00f4t F, et al. Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation. Clin J Am Soc Nephrol. 2016; [Epub ahead of print]","DOI":"10.2215\/CJN.06440616"},{"key":"727_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12874-015-0016-z","volume":"15","author":"CT Cunningham","year":"2015","unstructured":"Cunningham CT, Quan H, Hemmelgarn B, Noseworthy T, Beck CA, Dixon E, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol. 2015;15:32.","journal-title":"BMC Med Res Methodol"},{"key":"727_CR23","first-page":"821","volume":"60","author":"C Cook","year":"2000","unstructured":"Cook C, Health F, Thompson RA. Meta-Analysis of Response Rates in Web- or Internet-Based Survey. Educ Psychol. Measurement. 2000;60:821\u201336.","journal-title":"Measurement"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T19:41:56Z","timestamp":1659728516000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0727-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0727-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,28]]},"article-number":"324"}}